Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Effect of a MUC5AC Antibody (NPC-1C) Administered With Second-Line Gemcitabine and Nab-Paclitaxel on the Survival of Patients With Advanced Pancreatic Ductal Adenocarcinoma: A Randomized Clinical Trial.
Journal: JAMA network open
Published: January 05, 2023
Care Patterns and Overall Survival in Patients With Early-Onset Metastatic Colorectal Cancer.
Journal: JCO oncology practice
Published: May 27, 2021
Prospective Phase II Trials Validate the Effect of Neoadjuvant Chemotherapy on Pattern of Recurrence in Pancreatic Adenocarcinoma.
Journal: Annals of surgery
Published: October 21, 2020
Revisiting MET: Clinical Characteristics and Treatment Outcomes of Patients with Locally Advanced or Metastatic, MET-Amplified Esophagogastric Cancers.
Journal: The oncologist
Published: April 06, 2020
Author Correction: Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers.
Journal: Nature medicine
Published: November 21, 2019
Hypofractionated Radiation Therapy for Unresectable/Locally Recurrent Intrahepatic Cholangiocarcinoma.
Journal: Annals of surgical oncology
Published: July 20, 2019
Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer: A Phase 2 Clinical Trial.
Journal: JAMA oncology
Published: May 31, 2019
TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion-Positive Intrahepatic Cholangiocarcinoma.
Journal: Cancer discovery
Published: February 13, 2019
Pencil Beam Scanning Proton Beam Chemoradiation Therapy With 5-Fluorouracil and Mitomycin-C for Definitive Treatment of Carcinoma of the Anal Canal: A Multi-institutional Pilot Feasibility Study.
Journal: International journal of radiation oncology, biology, physics
Published: November 27, 2018
Case 32-2018: A 36-Year-Old Pregnant Woman with Newly Diagnosed Adenocarcinoma.
Journal: The New England journal of medicine
Published: October 18, 2018
Total Neoadjuvant Therapy With FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma: A Phase 2 Clinical Trial.
Journal: JAMA oncology
Published: May 26, 2018
Last Updated: 09/26/2026